Diabetes, Vol 44, Issue 1 75-79, Copyright © 1995 by American Diabetes Association

ARTICLES

Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted beta-cells

Y Ogawa, Y Noma, AM Davalli, YJ Wu, B Thorens, S Bonner-Weir and GC Weir
E.P. Joslin Laboratories, Joslin Diabetes Center, Boston, MA 02215.

Either 200 or 400 syngeneic islets were transplanted under the kidney capsule of normal or streptozocin-induced diabetic B6/AF1 mice. The diabetic mice with 400 islets became normoglycemic, but those with 200 islets, an insufficient number, were still diabetic after the transplantation (Tx). Two weeks after Tx, GLUT2 expression in the islet grafts was evaluated by immunofluorescence and Western blots, and graft function was examined by perfusion of the graft-bearing kidney. Immunofluorescence for GLUT2 was dramatically reduced in the beta-cells of grafts with 200 islets exposed to hyperglycemia. However, it was plentiful in grafts with 400 islets in a normoglycemic environment. Densitometric analysis of Western blots on graft homogenates demonstrated that GLUT2 protein levels in the islets, when exposed to chronic hyperglycemia for 2 weeks, were decreased to 16% of those of normal recipients. Moreover, these grafts had defective glucose-induced insulin secretion, while the effects of arginine were preserved. We conclude that GLUT2 expression in normal beta-cells is promptly down-regulated during exposure to hyperglycemia and may contribute to the loss of glucose-induced secretion of diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. T. Grey, C. Longo, T. Shukri, V. I. Patel, E. Csizmadia, S. Daniel, M. B. Arvelo, V. Tchipashvili, and C. Ferran Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves {beta} Cell Mass and Function J. Immunol., June 15, 2003; 170(12): 6250 - 6256. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, M. Glandt, G. Xu, Y. B. Ahn, N. Trivedi, S. Bonner-Weir, and G. C. Weir Critical Reduction in beta -Cell Mass Results in Two Distinct Outcomes over Time. ADAPTATION WITH IMPAIRED GLUCOSE TOLERANCE OR DECOMPENSATED DIABETES J. Biol. Chem., January 24, 2003; 278(5): 2997 - 3005. [Abstract] [Full Text] [PDF]

				M. Prentki, E. Joly, W. El-Assaad, and R. Roduit Malonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity: Role in {beta}-Cell Adaptation and Failure in the Etiology of Diabetes Diabetes, December 1, 2002; 51(90003): S405 - 413. [Abstract] [Full Text] [PDF]

				A. Abderrahmani, M. Steinmann, V. Plaisance, G. Niederhauser, J.-A. Haefliger, V. Mooser, C. Bonny, P. Nicod, and G. Waeber The Transcriptional Repressor REST Determines the Cell-Specific Expression of the Human MAPK8IP1 Gene Encoding IB1 (JIP-1) Mol. Cell. Biol., November 1, 2001; 21(21): 7256 - 7267. [Abstract] [Full Text] [PDF]

				L. Wu, J. D. Fritz, and A. C. Powers Different Functional Domains of GLUT2 Glucose Transporter Are Required for Glucose Affinity and Substrate Specificity Endocrinology, October 1, 1998; 139(10): 4205 - 4212. [Abstract] [Full Text] [PDF]

				S. Gremlich, R. Roduit, and B. Thorens Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic beta Cells. COMPARISON WITH THE EFFECTS OF FATTY ACIDS J. Biol. Chem., February 7, 1997; 272(6): 3216 - 3222. [Abstract] [Full Text] [PDF]